To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene SETD1BTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
175 supporting clones for gene SETD1B back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
CX872943 embryonic stem .a 1 to 767 1 to 767   tiling clone,   767/767
(100 %)
0 diff
(100 %id)
NM_015048.1   .a 1 to 8195 1 to 8195 exact RefSeq,   8195/8195
(100 %)
0 diff
(100 %id)
AA030728   .a 74 to 1186 1 to 1112   tiling clone,   1112/1114
(99 %)
7 diff
(99.4 %id)
CN483458 eye .a 176 to 766 1 to 591       591/591
(100 %)
5 diff
(99.2 %id)
BE737165 adenocarcinoma, Pancreas .a 238 to 1037 1 to 791       791/988
(80 %)
38 diff
(96.2 %id)
BF956940 nervous_normal .a 278 to 527 25 to 274       250/278
(89 %)
2 diff
(99.3 %id)
BI045234 prostate_normal .a 278 to 527 26 to 276       251/283
(88 %)
7 diff
(97.6 %id)
BF770965 epid_tumor .a 290 to 806 12 to 527       516/528
(97 %)
7 diff
(98.7 %id)
CV320890 lung_normal .a 322 to 666 1 to 349       349/350
(99 %)
31 diff
(91.2 %id)
BF850303 lung_normal .a 348 to 629 1 to 279       279/287
(97 %)
11 diff
(96.2 %id)
BF925317 nervous_tumor .a 417 to 960 547 to 3     Submitted on the opposite strand 545/550
(99 %)
6 diff
(99.0 %id)
BF850300 lung_normal .a 442 to 654 1 to 216       216/216
(100 %)
8 diff
(96.3 %id)
BF894326 marrow .a 454 to 965 526 to 18     Submitted on the opposite strand 509/530
(96 %)
2 diff
(99.7 %id)
BF925259 nervous_tumor .a 457 to 960 521 to 22     Submitted on the opposite strand 500/521
(95 %)
1 diff
(99.9 %id)
BF769427 epid_tumor .a 480 to 960 480 to 1     Submitted on the opposite strand 480/480
(100 %)
7 diff
(98.6 %id)
BF925253 nervous_tumor .a 497 to 965 495 to 27     Submitted on the opposite strand 469/495
(94 %)
2 diff
(99.6 %id)
BF770963 epid_tumor .a 498 to 914 421 to 3     Submitted on the opposite strand 419/421
(99 %)
0 diff
(100 %id)
BF925885 nervous_tumor .a 504 to 969 481 to 16     Submitted on the opposite strand 466/481
(96 %)
0 diff
(100 %id)
BF894328 marrow .a 549 to 965 437 to 20     Submitted on the opposite strand 418/439
(95 %)
0 diff
(100 %id)
BF926677 nervous_tumor .a 549 to 969 438 to 20     Submitted on the opposite strand 419/442
(94 %)
1 diff
(99.8 %id)
BF770970 epid_tumor .a 600 to 960 360 to 3     Submitted on the opposite strand 358/360
(99 %)
0 diff
(100 %id)
BF923266 nervous_tumor .a 665 to 1113 16 to 464   tiling clone,   449/464
(96 %)
8 diff
(98.3 %id)
BG979513 colon_normal .a 723 to 957 246 to 12       235/246
(95 %)
0 diff
(100 %id)
BF820727 kidney_tumor .a 981 to 1262 1 to 278   tiling clone,   278/308
(90 %)
32 diff
(89.7 %id)
AW407487 lymph .a 1246 to 1389 1 to 144   tiling clone,   144/144
(100 %)
4 diff
(97.3 %id)
TI_154146964   .a 1252 to 1668 81 to 496   tiling clone,   416/417
(99 %)
5 diff
(98.9 %id)
CR747179 fibrotheoma, ovary .a 1745 to 2079 1 to 335   tiling clone,   335/335
(100 %)
0 diff
(100 %id)
BF195596 fibrotheoma, ovary .a 2124 to 2359 235 to 1   tiling clone,   235/238
(98 %)
3 diff
(98.8 %id)
EG328672 pooled .a 2694 to 3012 319 to 1   tiling clone, Submitted on the opposite strand 319/319
(100 %)
0 diff
(100 %id)
CR977507 T-Lymphocytes .a 3226 to 4004 1 to 780   tiling clone,   780/780
(100 %)
1 diff
(99.9 %id)
AB028999 brain .a 3363 to 8194 1 to 4833   tiling clone, available from KIAA,   4833/4833
(100 %)
4 diff
(100.0 %id)
BF813059 colon_ins .a 3423 to 3765 7 to 348       342/348
(98 %)
6 diff
(98.3 %id)
BG997228 head_neck .a 3426 to 3819 117 to 510       394/510
(77 %)
7 diff
(98.7 %id)
BQ307833 breast .a 3450 to 3787 18 to 359       342/365
(93 %)
6 diff
(98.4 %id)
BG945699 bladder_tumor .a 3472 to 3741 1 to 271       271/272
(99 %)
10 diff
(96.4 %id)
BI029489 marrow .a 3506 to 3838 1 to 336       336/336
(100 %)
15 diff
(95.6 %id)
BF847725 lung_normal .a 3556 to 3828 275 to 3     Submitted on the opposite strand 273/275
(99 %)
0 diff
(100 %id)
BQ326759 colon_normal .a 3586 to 3814 1 to 228       228/228
(100 %)
3 diff
(98.7 %id)
BU902253 leiomyosarcoma, uterus .a 3636 to 4683 1 to 1047       1047/1133
(92 %)
29 diff
(97.5 %id)
BG015931 placenta_normal .a 3852 to 4280 430 to 1       430/432
(99 %)
15 diff
(96.6 %id)
CR981649 T-Lymphocytes .a 3871 to 4357 488 to 1     Submitted on the opposite strand 488/488
(100 %)
1 diff
(99.8 %id)
CA394925 eye, RPE/choroid .a 3936 to 4374 1 to 439       439/439
(100 %)
6 diff
(98.7 %id)
CN426774 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 4458 to 4636 9 to 187       179/187
(95 %)
6 diff
(96.8 %id)
DA719256   .a 4709 to 5279 2 to 572   tiling clone, capped   571/571
(100 %)
3 diff
(99.5 %id)
Z28532 leg muscle, skeletal muscle .a 4765 to 5047 1 to 283       283/286
(98 %)
1 diff
(99.7 %id)
CT000881 T-Lymphocytes .a 4783 to 5450 1 to 670       670/680
(98 %)
4 diff
(99.5 %id)
BE818306 breast_normal .a 4925 to 5199 1 to 276       276/316
(87 %)
6 diff
(98.2 %id)
BF091463 testis_normal .a 4991 to 5161 1 to 171       171/171
(100 %)
0 diff
(100 %id)
BQ320700 colon .a 5039 to 5134 23 to 119       97/120
(80 %)
6 diff
(95.0 %id)
CN426772 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5087 to 5610 1 to 524       524/524
(100 %)
0 diff
(100 %id)
BU526997 epidermoid carcinoma, cell line, lung .a 5243 to 6052 814 to 1     Submitted on the opposite strand 814/939
(86 %)
33 diff
(96.5 %id)
Z24788 leg muscle, skeletal muscle .a 5255 to 5582 330 to 2       329/338
(97 %)
1 diff
(99.8 %id)
EG328411 pooled .a 5512 to 5633 122 to 1     Submitted on the opposite strand 122/122
(100 %)
1 diff
(99.2 %id)
EG328410 pooled .a 5550 to 5747 1 to 197       197/197
(100 %)
1 diff
(99.5 %id)
BM476922 leiomyosarcoma, uterus .a 5559 to 6255 1 to 702       702/1185
(59 %)
17 diff
(98.6 %id)
CN426773 embryonic stem cells, DMSO-treated H9 cellline .a 5568 to 6127 1 to 560       560/560
(100 %)
4 diff
(99.3 %id)
CN426775 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 5671 to 6247 1 to 577       577/577
(100 %)
3 diff
(99.5 %id)
BC080192 Eye, retinoblastoma .a 5835 to 8164 1 to 2331   tiling clone, available from MGC, AAA   2331/2331
(100 %)
2 diff
(100.0 %id)
BU171000 eye, retinoblastoma .a 5836 to 6664 1 to 834   available from MGC,   834/877
(95 %)
18 diff
(98.0 %id)
DA540542 lung .a 6032 to 6411 2 to 381   capped   380/380
(100 %)
1 diff
(99.8 %id)
BI752608 brain .a 6059 to 6717 1 to 669       669/681
(98 %)
23 diff
(96.7 %id)
TI_57219651   .a 6059 to 6717 63 to 731       669/743
(90 %)
23 diff
(97.0 %id)
BQ420304 embryonal carcinoma, cell line, testis .a 6072 to 7054 1 to 1002   available from MGC,   1002/1140
(87 %)
6 diff
(99.5 %id)
BC047909 Testis, embryonal carcinoma .a 6082 to 8194 1 to 2114   tiling clone, available from MGC, AAA   2114/2114
(100 %)
2 diff
(100.0 %id)
AA478673 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6096 to 6597 1 to 499       499/499
(100 %)
6 diff
(98.8 %id)
BM459795 leiomyosarcoma, uterus .a 6137 to 6812 47 to 722       676/988
(68 %)
6 diff
(99.4 %id)
BM561816 blood, natural killer cells, cell line .a 6269 to 7277 1 to 1017       1017/1028
(98 %)
41 diff
(96.1 %id)
AI498725 anaplastic oligodendroglioma, brain .a 6396 to 6541 169 to 24       146/169
(86 %)
0 diff
(100 %id)
BQ689280 ductal carcinoma, cell line, Pancreas .a 6417 to 7209 1 to 799       799/985
(81 %)
9 diff
(99.1 %id)
AA625506 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6466 to 6677 1 to 209       209/209
(100 %)
8 diff
(96.2 %id)
CT003980 T-Lymphocytes .a 6482 to 7145 1 to 663       663/663
(100 %)
1 diff
(99.9 %id)
BQ581852 insulinoma, Pancreas .a 6527 to 7069 1 to 543       543/543
(100 %)
5 diff
(99.1 %id)
BM714084 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6533 to 6962 1 to 430   fully sequenced,   430/430
(100 %)
0 diff
(100 %id)
AA479215 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 6775 to 7159 385 to 1       385/385
(100 %)
3 diff
(99.3 %id)
BM675269 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 6932 to 7398 486 to 19   fully sequenced, AAA   468/468
(100 %)
1 diff
(99.8 %id)
DB318116 lung .a 7636 to 8194 559 to 1       559/559
(100 %)
3 diff
(99.5 %id)
CR598662 HeLa cells Cot 25-normalized .b 1 to 2090 1 to 1659 K161F T162L K163T K164G H165L ... tiling clone, Suspected internal deletion 1659/1659
(100 %)
0 diff
(100 %id)
BX341628   .b 1 to 1342 1 to 909     Suspected internal deletion 909/909
(100 %)
3 diff
(99.7 %id)
BX341627   .b 1136 to 2090 953 to 1   tiling clone,   953/953
(100 %)
8 diff
(99.2 %id)
BX369646   .b 1209 to 2122 1 to 912   tiling clone,   912/915
(99 %)
17 diff
(98.2 %id)
BX369647   .b 1212 to 2122 1 to 909   tiling clone,   909/909
(100 %)
19 diff
(98.0 %id)
R71438 placenta .c-u 1 to 347 1 to 347   tiling clone,   347/351
(98 %)
12 diff
(96.6 %id)
BX099459 placenta .c-u 3 to 663 1 to 662       662/662
(100 %)
1 diff
(99.9 %id)
BU738563 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 194 to 693 517 to 18   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 500/520
(96 %)
0 diff
(100 %id)
BM713127 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 200 to 682 1 to 483       483/483
(100 %)
0 diff
(100 %id)
BM716511 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c-u 201 to 693 1 to 492       492/520
(94 %)
6 diff
(98.9 %id)
AI744662 pooled .c-u 353 to 725 373 to 1       373/373
(100 %)
4 diff
(99.0 %id)
R71092 placenta .c-u 354 to 707 359 to 1       359/359
(100 %)
9 diff
(97.5 %id)
BG287047 bladder, transitional cell papilloma, cell line .c-u 549 to 1337 1 to 792       792/1022
(77 %)
34 diff
(96.7 %id)
BQ927443 large cell carcinoma, lung .c-u 549 to 1478 1 to 930   tiling clone,   930/930
(100 %)
16 diff
(98.3 %id)
BQ436077 embryonal carcinoma, cell line, testis .c-u 551 to 1272 1 to 722       722/724
(99 %)
3 diff
(99.6 %id)
BG774383 choriocarcinoma, placenta .c-u 557 to 1501 1 to 945       945/959
(98 %)
23 diff
(97.7 %id)
CR992383 T-Lymphocytes .c-u 562 to 1360 1 to 800       800/801
(99 %)
3 diff
(99.7 %id)
BE281116 choriocarcinoma, placenta .c-u 567 to 1222 17 to 673       657/673
(97 %)
6 diff
(99.2 %id)
BG336796 choriocarcinoma, placenta .c-u 579 to 1309 1 to 728       728/909
(80 %)
16 diff
(98.3 %id)
BU957528 adenocarcinoma, cell line, breast .c-u 701 to 1608 1 to 920   tiling clone,   920/920
(100 %)
26 diff
(97.2 %id)
BU190743 ductal carcinoma, cell line, Pancreas .c-u 847 to 1332 1 to 491       491/996
(49 %)
6 diff
(99.4 %id)
BU185947 ductal carcinoma, cell line, Pancreas .c-u 847 to 1663 1 to 830   tiling clone,   830/915
(90 %)
36 diff
(96.1 %id)
BF771245 epid_tumor .c-u 866 to 1226 371 to 12     Submitted on the opposite strand 360/371
(97 %)
0 diff
(100 %id)
DW424147 Liver .c-u 961 to 1242 8 to 289       282/289
(97 %)
5 diff
(98.3 %id)
CN426770 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1 to 538 1 to 538   tiling clone,   538/538
(100 %)
0 diff
(100 %id)
BG977522 colon_ins .d 62 to 613 1 to 552       550/552
(99 %)
14 diff
(97.5 %id)
AL134228 brain .d 170 to 717 1 to 549   tiling clone,   549/549
(100 %)
2 diff
(99.7 %id)
CR997077 T-Lymphocytes .e 1 to 452 1 to 452   tiling clone,   452/452
(100 %)
0 diff
(100 %id)
BF893314 marrow .e 161 to 537 1 to 375   tiling clone,   375/375
(100 %)
6 diff
(98.4 %id)
T70947 Liver .f-u 1 to 340 1 to 350   tiling clone,   350/351
(99 %)
6 diff
(98.3 %id)
BU552987 ovary, teratocarcinoma, cell line .f-u 588 to 1430 1 to 849   tiling clone,   849/909
(93 %)
13 diff
(98.6 %id)
BE394210 endometrium, adenocarcinoma cell line, uterus .f-u 604 to 1320 1 to 713   tiling clone,   713/722
(98 %)
18 diff
(97.6 %id)
T70895 Liver .f-u 1128 to 1543 425 to 11   tiling clone,   415/425
(97 %)
0 diff
(100 %id)
DA609236   .g-u 1 to 469 2 to 471   tiling clone, capped   470/470
(100 %)
1 diff
(99.8 %id)
AI949074 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .g-u 136 to 581 448 to 1       448/448
(100 %)
4 diff
(99.2 %id)
BY995110   .g-u 154 to 836 1 to 683   tiling clone,   683/683
(100 %)
1 diff
(99.9 %id)
AA343038 Spleen .g-u 159 to 577 417 to 1       417/419
(99 %)
4 diff
(99.1 %id)
BP395503 pancreatic islet .g-u 199 to 583 1 to 386     Submitted on the opposite strand 386/386
(100 %)
2 diff
(99.5 %id)
CD366251 Alveolar Macrophage, lung .g-u 207 to 577 388 to 19   AAA   370/370
(100 %)
1 diff
(99.8 %id)
AI569703 anaplastic oligodendroglioma, brain .g-u 211 to 579 369 to 1       369/369
(100 %)
0 diff
(100 %id)
F33234 pectoral muscle (after mastectomy) .g-u 229 to 395 1 to 166       166/166
(100 %)
6 diff
(96.4 %id)
BF982725 duodenal adenocarcinoma, cell line, small intestine .g-u 242 to 732 8 to 503       496/503
(98 %)
6 diff
(98.9 %id)
AW779856 Kidney .g-u 317 to 577 263 to 2       262/263
(99 %)
0 diff
(100 %id)
BE676911 follicular carcinoma, thyroid .g-u 320 to 580 267 to 7       261/274
(95 %)
0 diff
(100 %id)
AI273135 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g-u 344 to 577 249 to 16   AAA   234/234
(100 %)
0 diff
(100 %id)
AI419821 pooled .g-u 417 to 794 1 to 378     Submitted on the opposite strand 378/378
(100 %)
0 diff
(100 %id)
BE501972 Kidney .g-u 423 to 824 405 to 3       403/405
(99 %)
0 diff
(100 %id)
CN426777 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g-u 465 to 891 1 to 427       427/427
(100 %)
0 diff
(100 %id)
AA300053 uterus .g-u 477 to 698 1 to 225       225/225
(100 %)
3 diff
(98.7 %id)
AA368966 placenta .g-u 487 to 716 1 to 230       230/230
(100 %)
1 diff
(99.6 %id)
BM545418 brain, hippocampus .g-u 494 to 1450 27 to 984 L54F F55I L56P S57F R59Q ...     958/1080
(88 %)
27 diff
(97.5 %id)
BM742412 Ascites, stomach .g-u 659 to 1299 1 to 642 L54F F55I L56P S57F R59Q ...     642/642
(100 %)
4 diff
(99.4 %id)
BM459871 leiomyosarcoma, uterus .g-u 721 to 1592 22 to 907   tiling clone,   886/1099
(80 %)
37 diff
(96.7 %id)
BX393552 Neuroblastoma Cot 10-normalized .g-u 750 to 1596 16 to 861       846/861
(98 %)
6 diff
(99.4 %id)
BE868651 adenocarcinoma, colon .g-u 766 to 1368 1 to 618       618/933
(66 %)
31 diff
(96.7 %id)
CU444520 epidermis .g-u 905 to 1490 607 to 22     Submitted on the opposite strand 586/620
(94 %)
0 diff
(100 %id)
CK024044 brain/CNS, Human Brain - Frontal Cortex .g-u 916 to 1611 1 to 686   AAA   686/686
(100 %)
16 diff
(97.7 %id)
CN426776 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g-u 919 to 1484 9 to 574       566/574
(98 %)
7 diff
(98.8 %id)
CA426000 Bone, Subchondral Bone .g-u 959 to 1595 657 to 19   AAA   639/639
(100 %)
8 diff
(98.8 %id)
BI004105 head_normal .g-u 962 to 1264 321 to 20       302/321
(94 %)
0 diff
(100 %id)
BI004250 head_normal .g-u 962 to 1264 303 to 1       303/303
(100 %)
6 diff
(98.1 %id)
BF339128 brain, glioblastoma with EGFR amplification .g-u 968 to 1613 1 to 645       645/672
(95 %)
12 diff
(98.3 %id)
CU448850 epidermis .g-u 969 to 1377 412 to 4     Submitted on the opposite strand 409/413
(99 %)
0 diff
(100 %id)
CU453702 epidermis .g-u 969 to 1593 632 to 8     Submitted on the opposite strand 625/633
(98 %)
0 diff
(100 %id)
BM314129 insulinoma, Pancreas .g-u 1030 to 1610 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
CK905205 insulinoma, Pancreas .g-u 1030 to 1235 1 to 206   fully sequenced,   206/206
(100 %)
4 diff
(98.1 %id)
BQ130834 insulinoma, Pancreas .g-u 1030 to 1484 1 to 455       455/455
(100 %)
3 diff
(99.4 %id)
AK000810 adipose tissue .g-u 1032 to 1582 1 to 551   available from FLJ, AAA   551/551
(100 %)
2 diff
(99.7 %id)
AL049035 testis .g-u 1049 to 1587 1 to 539       539/542
(99 %)
2 diff
(99.7 %id)
AL049036 testis .g-u 1049 to 1571 524 to 1       524/524
(100 %)
1 diff
(99.9 %id)
BY797605 eye .g-u 1088 to 1612 587 to 63   AAA Submitted on the opposite strand 525/525
(100 %)
3 diff
(99.5 %id)
AA761184 germinal center B cell .g-u 1123 to 1611 497 to 9       489/497
(98 %)
0 diff
(100 %id)
AW337138 adenocarcinoma, Pancreas .g-u 1128 to 1596 475 to 7       469/475
(98 %)
0 diff
(100 %id)
AV710965 adrenal cortico adenoma for Cushing'ssyndrome .g-u 1142 to 1610 1 to 469   AAA   469/469
(100 %)
1 diff
(99.8 %id)
AI652792 pooled germ cell tumors .g-u 1142 to 1589 471 to 24   AAA   448/448
(100 %)
7 diff
(98.5 %id)
BQ130579 insulinoma, Pancreas .g-u 1148 to 1612 482 to 18   AAA   465/466
(99 %)
1 diff
(99.8 %id)
BM313848 insulinoma, Pancreas .g-u 1149 to 1593 445 to 1       445/445
(100 %)
1 diff
(99.8 %id)
AI469951 pooled .g-u 1154 to 1582 444 to 16   AAA   429/429
(100 %)
6 diff
(98.7 %id)
AW051843 pooled .g-u 1156 to 1589 446 to 12   AAA   435/435
(100 %)
4 diff
(99.1 %id)
AI366758 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .g-u 1201 to 1614 414 to 1       414/414
(100 %)
23 diff
(94.5 %id)
CK905204 insulinoma, Pancreas .g-u 1205 to 1575 372 to 1   fully sequenced,   372/372
(100 %)
8 diff
(97.9 %id)
AW838327 leiomios .g-u 1206 to 1507 324 to 24       301/326
(92 %)
0 diff
(100 %id)
AA621321   .g-u 1232 to 1592 366 to 6       361/366
(98 %)
0 diff
(100 %id)
AA364169 pineal body .g-u 1245 to 1570 1 to 329       329/329
(100 %)
3 diff
(99.1 %id)
AW963451   .g-u 1246 to 1612 1 to 367   tiling clone, AAA   367/367
(100 %)
0 diff
(100 %id)
AA300054 uterus .g-u 1254 to 1595 346 to 1       346/346
(100 %)
4 diff
(98.9 %id)
AW104693 ovary, tumor, 5 pooled (see description) .g-u 1256 to 1611 356 to 1       356/357
(99 %)
0 diff
(100 %id)
CN426771 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .g-u 1259 to 1536 278 to 1     Submitted on the opposite strand 278/278
(100 %)
1 diff
(99.7 %id)
AI569312 adenocarcinoma, Pancreas .g-u 1280 to 1592 314 to 2       313/314
(99 %)
0 diff
(100 %id)
AW149962 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .g-u 1302 to 1582 286 to 1       286/286
(100 %)
10 diff
(96.6 %id)
AI471900 lymph node, lymphoma, follicular mixed small and largecell .g-u 1368 to 1599 250 to 17   AAA   234/234
(100 %)
5 diff
(97.9 %id)
BF438274 Prostate .g-u 1406 to 1592 188 to 2       187/188
(99 %)
0 diff
(100 %id)
BX348645 Neuroblastoma Cot 10-normalized .g-u 1453 to 1596 1 to 142       142/147
(96 %)
7 diff
(95.3 %id)
AI682598 adenocarcinoma, Pancreas .g-u 1455 to 1593 170 to 32   AAA   139/139
(100 %)
3 diff
(97.9 %id)
EC533504 Prostate .g-u 1495 to 1585 90 to 2       89/94
(94 %)
0 diff
(100 %id)
EC461184 Prostate .g-u 1503 to 1613 118 to 9       110/118
(93 %)
0 diff
(100 %id)
EC476004 Prostate .g-u 1503 to 1614 120 to 11   AAA   110/110
(100 %)
6 diff
(94.6 %id)
EC541740 Prostate .g-u 1503 to 1611 110 to 3       108/110
(98 %)
0 diff
(100 %id)
EC542549 Prostate .g-u 1503 to 1611 111 to 3       109/111
(98 %)
0 diff
(100 %id)
EC530285 Prostate .g-u 1521 to 1609 1 to 89       89/92
(96 %)
5 diff
(94.6 %id)
EC456170 Prostate .g-u 1522 to 1611 1 to 88       88/88
(100 %)
4 diff
(95.5 %id)
EC513512 Prostate .g-u 1522 to 1610 1 to 87       87/87
(100 %)
5 diff
(94.3 %id)
EC545797 Prostate .g-u 1524 to 1609 4 to 87       84/89
(94 %)
9 diff
(89.9 %id)
BF752589 breast_normal .h -8 to 286 8 to 303 R3A F6Y E8R L9T L10D ... tiling clone,   296/303
(97 %)
6 diff
(98.1 %id)
DB314726   Gene SETD1B, variant not shown              
DA469615   Gene SETD1B, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c-u, .d, .e, .f-u, .g-u, .h Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI